- Home
- MURA vs LIQT Comparison
MURA vs LIQT Comparison
Compare MURA & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- LIQT
- Stock Information
- Founded
- MURA 2013
- LIQT 2004
- Country
- MURA Ireland
- LIQT Denmark
- Employees
- MURA N/A
- LIQT N/A
- Industry
- MURA
- LIQT Industrial Machinery/Components
- Sector
- MURA
- LIQT Technology
- Exchange
- MURA Nasdaq
- LIQT Nasdaq
- Market Cap
- MURA 45.8M
- LIQT 16.9M
- IPO Year
- MURA N/A
- LIQT N/A
- Fundamental
- Price
- MURA $2.62
- LIQT $1.63
- Analyst Decision
- MURA Strong Buy
- LIQT Strong Buy
- Analyst Count
- MURA 4
- LIQT 2
- Target Price
- MURA $13.00
- LIQT $4.70
- AVG Volume (30 Days)
- MURA 206.7K
- LIQT 11.0K
- Earning Date
- MURA 05-14-2025
- LIQT 05-14-2025
- Dividend Yield
- MURA N/A
- LIQT N/A
- EPS Growth
- MURA N/A
- LIQT N/A
- EPS
- MURA N/A
- LIQT N/A
- Revenue
- MURA N/A
- LIQT $14,986,815.00
- Revenue This Year
- MURA $34.35
- LIQT $32.70
- Revenue Next Year
- MURA N/A
- LIQT $15.79
- P/E Ratio
- MURA N/A
- LIQT N/A
- Revenue Growth
- MURA N/A
- LIQT N/A
- 52 Week Low
- MURA $0.95
- LIQT $1.34
- 52 Week High
- MURA $4.74
- LIQT $3.20
- Technical
- Relative Strength Index (RSI)
- MURA 50.82
- LIQT 55.38
- Support Level
- MURA $2.59
- LIQT $1.48
- Resistance Level
- MURA $2.72
- LIQT $1.80
- Average True Range (ATR)
- MURA 0.15
- LIQT 0.08
- MACD
- MURA -0.02
- LIQT 0.02
- Stochastic Oscillator
- MURA 29.41
- LIQT 57.50
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.